Stefan Ibach
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Volker Kunzmann (2 shared papers)Salah‐Eddin Al‐Batran (2 shared papers)Jörg Trojan (2 shared papers)S Daum (2 shared papers)Michael Schenk (2 shared papers)Dirk Behringer (2 shared papers)Florian Lordick (3 shared papers)Frank Kullmann (2 shared papers)
- Journals
- Blood (2 papers)Annals of Hematology (1 paper)British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)JCO Clinical Cancer Informatics (1 paper)
- Partner nations
- GermanyFranceUnited Kingdom
In The Last Decade
Stefan Ibach
8 papers receiving 149 citations
Peers
Comparison fields: 5 of 29
- Genetics 70
- Pathology and Forensic Medicine 68
- Immunology 53
- Gastroenterology 13
- Oncology 45
Countries citing papers authored by Stefan Ibach
This map shows the geographic impact of Stefan Ibach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Ibach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Ibach more than expected).
Fields of papers citing papers by Stefan Ibach
This network shows the impact of papers produced by Stefan Ibach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Ibach. The network helps show where Stefan Ibach may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Ibach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 66 | |
| 2 | 2013 | 30 | |
| 3 | 2013 | 30 | |
| 4 | 2017 | 13 | |
| 5 | Phase II Study of Rituximab in Combination With Fludarabine in Patients With Chronic Lymphocytic Leukemia | 2002 | 6 |
| 6 | 2018 | 5 | |
| 7 | 2024 | 2 | |
| 8 | 2022 | 2 | |
| 9 | 2024 | 0 | |
| 10 | 2014 | 0 |
About Stefan Ibach
Stefan Ibach is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Hematology, having authored 10 papers that have together received 154 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Gastric Cancer Management and Outcomes (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Genetics (70 citations), Pathology and Forensic Medicine (68 citations), Immunology (53 citations), Gastroenterology (13 citations) and Oncology (45 citations). Stefan Ibach has collaborated with scholars based in Germany, France and United Kingdom. Frequent co-authors include Volker Kunzmann, Salah‐Eddin Al‐Batran, Jörg Trojan, S Daum, Michael Schenk, Dirk Behringer, Florian Lordick, Frank Kullmann, Horst Lindhofer and Maren Knödler. Their work appears in journals such as Blood, Annals of Hematology, British Journal of Cancer, Journal of Clinical Oncology and JCO Clinical Cancer Informatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.